Navigation Links
Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip
Date:6/12/2011

S. BY CANCER CLASSIFICATION 162

Breast Cancer MDx Platforms 162

TABLE 67 BREAST CANCER MDX TECHNOLOGY PLATFORMS 163

Breast Cancer Multivariate Diagnostic Tests 164

TABLE 68 COMMERCIAL LANDSCAPE FOR MULTIVARIATE BREAST CANCER TESTS, BY PARAMETER 164

TABLE 68 (CONTINUED) 165

Breast Cancer Multivariate … (Continued) 166

Regulatory Status of Gene Profiling Diagnostic Tests 167

TABLE 69 FDA REGULATORY POSITION ON IVDMIA 167

CERVICAL CANCER 168

TABLE 70 COMMERCIAL LANDSCAPE FOR HPV TESTS 168

TABLE 70 (CONTINUED) 169

COLORECTAL CANCER 170

Conventional Colorectal Cancer Screening Tests 170

TABLE 71 CURRENT SCREENING AND DIAGNOSTICS TESTS FOR COLORECTAL CANCER 171

Molecular Colorectal Cancer Diagnostics Tests 172

TABLE 72 COMMERCIAL LANDSCAPE FOR COLORECTAL MOLECULAR TESTS 172

Molecular Colorectal Cancer … (Continued) 173

CUP 174

TABLE 73 COMMERCIAL MDX PLATFORMS FOR TISSUE OF ORIGIN TESTS 175

GASTRIC CANCER 176

LUNG CANCER 177

Lung Cancer (Continued) 178

OVARIAN CANCER 179

TABLE 74 OVARIAN CANCER SCREENING TESTS 179

TABLE 75 OVARIAN CANCER DIAGNOSTIC TEST STATUS 180

PANCREATIC CANCER 180

PEDIATRIC CANCERS 181

PROSTATE CANCER 181

Prostate Cancer (Continued) 182

COMPREHENSIVE CANCER TESTS 183

STATUS OF BIOCHIP-BASED INFECTIOUS DISEASE DIAGNOSTICS 183

SEPSIS 183

TUBERCULOSIS 184

MRSA 184

INFLUENZA 185

OTHER INFECTIOUS DISEASES 185

STATUS OF BIOCHIP-BASED DME DIAGNOSTICS 186

DMES 186

TABLE 76 MICROARRAY-BASED DME DIAGNOSTICS TESTS 186

DMEs (Continued) 187

WARFARIN DOSING 188

TABLE 77 WARFARIN CYP PGX DIAGNOSTICS TEST COMPETITOR SPACE 189

TABLE 77 (CONTINUED) 190

Warfarin Dosing (Continued) 191'/>"/>

SOURCE S OF COMPETITIVE ADVANTAGE IN DNA MICROARRAYS 265
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology news :

1. Reportlinker Adds Biometrics: Technologies and Global Markets
2. Reportlinker Adds Enzymes in Drug Manufacturing
3. Reportlinker Adds Bioinformatics - A Global Market Overview
4. Reportlinker Adds Global Biometric Forecast to 2012
5. Reportlinker Adds Global Bioinformatics Industry
6. Reportlinker Adds Indian Biometric Market
7. Reportlinker Adds Biometrics: Technologies and Global Markets
8. Reportlinker Adds Global Biochip Markets: Microarrays and Lab-on-a-Chip
9. Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics
10. Reportlinker Adds Global Flow Cytometers Industry
11. Reportlinker Adds World Biometrics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2015)... Conn. , Aug. 17, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... its new sales campaign for Q4 2015. The new ... marketing team consisting of Amplitude Marketing Group ( http://amplitudemarketing.com/ ... Marketing Group is a leader in retail driven marketing ...
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that four of its ... solution, have officially been named FIDO Certified™ by ... of the certification, Synaptics, Natural ID™ fingerprint solutions ... Authentication Framework (UAF) standard and are interoperable among ...
(Date:8/6/2015)... 2015  Today, U.S. Congressman Mike Honda ... to learn firsthand how Silicon Valley technologies can ... a world leader in multi-factor identity management and ... federal agencies and commercial organizations achieve new levels ... "The vast majority of network breaches can be ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3Rep. Honda to Visit Crossmatch in Redwood City 2
... The Sixth Annual Sue Kim Hanson Lecture in Immunology on ... in honor of Sue Kim Hanson, MA, PhD 02, a ... with her husband and daughter, were passengers on United Airline ... Center on September 11, 2001. The lecture titled, Mechanisms ...
... Fisheries Service, has reported in an online scientific journal ... River dolphin, or baiji, during a six-week survey in ... extinct due to fishing and commercial development, which would ... of human activity. The research paper, published ...
... 2007)While the wily coyote reigns as top dog in much ... coexists with its larger relative, the wolf, according to a ... densities are more than 30 percent lower in areas that ... most recent edition of the Journal of Animal Ecology, details ...
Cached Biology News:Lecture to honor victim of Sept. 11 tragedy 2Scientists fear rare dolphin driven to extinction by human activities 2Who's afraid of the big, bad wolf? Coyotes 2
(Date:9/2/2015)... 2, 2015 Axovant Sciences Ltd. (NYSE:  AXON), a ... today announced upcoming presentations at three investor conferences: ... 2015 Healthcare Conference in New York ... 10 at 2:00 PM at the BioCentury NewsMakers Conference in ... Hotel & Conference Center , Thursday, September 17 at ...
(Date:9/2/2015)... , Sep. 02, 2015 ... has announced the addition of Jain PharmaBiotech,s new ... and Companies" to their offering. ... based on technologies and applications. The report starts ... for estimation of markets. Technologies include array comparative ...
(Date:9/2/2015)... Research and ... addition of Jain PharmaBiotech,s new report ... to their offering. The scope ... in situ hybridization (FISH), comparative genomic hybridization ... application of nanobiotechnology, microarrays, real-time polymerase chain ...
(Date:9/2/2015)... Sept. 2, 2015 Australian prostate cancer technology ... Australian science prize recognising ,outstanding, science that uses its ... globally launch a novel prostate cancer diagnostic test known ... level consortium taking out the peer-reviewed Australian Museum Eureka ... This prize is awarded for ground ...
Breaking Biology Technology:Axovant Sciences To Present At Upcoming Investor Conferences 2Axovant Sciences To Present At Upcoming Investor Conferences 3Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3
... Inc. (NASDAQ: VSGN ; TSX:VAS) today reported the results ... All dollar amounts referenced herein are in Canadian dollars unless ... cash equivalents totaled $8.6 million, compared with $23.5 million at ... As of January 31, 2009, our cash balance was $8.5 ...
... fast-acting(1) combination treatment option for millions of Americans ... AstraZeneca (NYSE: AZN ) ... Administration (FDA) has approved SYMBICORT (budesonide/formoterol fumarate dihydrate) ... of airflow obstruction in patients with chronic obstructive ...
... Arkion(R) Life Sciences has received a Section 18 Crisis ... effective March 1, 2009. The EPA approval means that ... sweet corn from marauding blackbirds and grackles for the ... applied to corn seed before planting and effectively stops ...
Cached Biology Technology:Vasogen Announces 2008 Year-End Results 2Vasogen Announces 2008 Year-End Results 3Vasogen Announces 2008 Year-End Results 4Vasogen Announces 2008 Year-End Results 5Vasogen Announces 2008 Year-End Results 6Vasogen Announces 2008 Year-End Results 7Vasogen Announces 2008 Year-End Results 8Vasogen Announces 2008 Year-End Results 9Vasogen Announces 2008 Year-End Results 10Vasogen Announces 2008 Year-End Results 11FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 2FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 3FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 4FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 5FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 6Crisis Exemption Granted to Market Avipel(R) Corn Seed Treatment in Louisiana 2